• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.

作者信息

Oyama F, Shimada H, Oyama R, Titani K, Ihara Y

机构信息

Division of Biomedical Polymer Science, School of Medicine, Fujita Health University, Aichi, Japan.

出版信息

J Neurochem. 1993 May;60(5):1658-64. doi: 10.1111/j.1471-4159.1993.tb13388.x.

DOI:10.1111/j.1471-4159.1993.tb13388.x
PMID:8473889
Abstract

To learn whether or not the levels of beta-amyloid protein precursor (APP) and tau mRNAs are related to the formation of beta-amyloid and neurofibrillary tangles, we quantified these mRNA levels in three cortical regions of 38 aged human brains, which were examined immunocytochemically for beta-amyloid and tangles. Marked individual variabilities were noted in APP and tau mRNA levels among elderly individuals. The mean APP mRNA level was slightly reduced in the beta-amyloid plaque (+2) group, but not in the plaque (+) group, compared to the plaque (-) group. Some brains in the plaque (-) group showed increased APP expression, the extent of which was not seen in the plaque (+) or (+2) group. The differences in the mean tau mRNA levels were not statistically significant among the tangle (-), (+), and (+2) groups. These results show that beta-protein and tau deposition do not accompany increased expression of the APP and tau genes, respectively, and thus suggest that factors other than gene expression may be at work in the progression of beta-amyloid and/or tangle formation in the aged human brain.

摘要

相似文献

1
Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.
J Neurochem. 1993 May;60(5):1658-64. doi: 10.1111/j.1471-4159.1993.tb13388.x.
2
Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau.
J Neuropathol Exp Neurol. 1991 Sep;50(5):560-78. doi: 10.1097/00005072-199109000-00004.
3
Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.在突变型tau转基因小鼠模型中,淀粉样前体蛋白的减少会增强神经原纤维缠结的形成。
Neurobiol Aging. 2017 Jul;55:202-212. doi: 10.1016/j.neurobiolaging.2017.03.031. Epub 2017 Apr 5.
4
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.在表达突变型tau蛋白和淀粉样前体蛋白(APP)的转基因小鼠中神经原纤维变性增强。
Science. 2001 Aug 24;293(5534):1487-91. doi: 10.1126/science.1058189.
5
A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain.老年人大脑中β-淀粉样蛋白前体水平与tau转录本之间的一种新关联。
J Neurochem. 1992 Sep;59(3):1117-25. doi: 10.1111/j.1471-4159.1992.tb08354.x.
6
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.将野生型人 tau 引入 APP 转基因小鼠中形成神经原纤维缠结。
Acta Neuropathol. 2014 May;127(5):685-98. doi: 10.1007/s00401-014-1259-1. Epub 2014 Feb 15.
7
Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination.
J Neurochem. 1994 Mar;62(3):1062-6. doi: 10.1046/j.1471-4159.1994.62031062.x.
8
Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.阿尔茨海默病综述:抑制淀粉样β和tau 缠结形成。
Int J Biol Macromol. 2021 Jan 15;167:382-394. doi: 10.1016/j.ijbiomac.2020.11.192. Epub 2020 Dec 2.
9
[Alzheimer's disease: lesions and their progression].[阿尔茨海默病:病变及其进展]
Rev Neurol (Paris). 1999;155 Suppl 4:S17-27.
10
Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.阿尔茨海默病可调节小鼠模型中的淀粉样斑块和神经原纤维缠结病理
Am J Pathol. 2008 Sep;173(3):762-72. doi: 10.2353/ajpath.2008.080175. Epub 2008 Jul 31.

引用本文的文献

1
Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer's Disease: An Animal Model.电针与司来吉兰联合治疗对阿尔茨海默病的影响:动物模型研究
Front Pharmacol. 2020 Dec 10;11:606480. doi: 10.3389/fphar.2020.606480. eCollection 2020.
2
The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".阿尔茨海默病的发病机制:对“淀粉样蛋白瀑布假说”的重新评估
Int J Alzheimers Dis. 2011 Feb 7;2011:630865. doi: 10.4061/2011/630865.
3
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.
非痴呆的阿尔茨海默病病理学中间阶段个体的神经元基因表达。
Neurobiol Aging. 2010 Apr;31(4):549-66. doi: 10.1016/j.neurobiolaging.2008.05.013. Epub 2008 Jun 24.
4
Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau.阿尔茨海默病异常高磷酸化tau蛋白对微管网络的破坏
Acta Neuropathol. 2007 May;113(5):501-11. doi: 10.1007/s00401-007-0207-8. Epub 2007 Mar 20.
5
High-performance liquid chromatography coupled with tandem mass spectrometry for the detection of amyloid Beta peptide related with Alzheimer's disease.高效液相色谱-串联质谱联用技术用于检测与阿尔茨海默病相关的β淀粉样肽。
J Biomol Tech. 2005 Dec;16(4):356-63.
6
Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.阿尔茨海默病中钠钾ATP酶mRNA水平与斑块负荷
J Mol Neurosci. 1997 Dec;9(3):151-66. doi: 10.1007/BF02800498.